New roles for renin and prorenin in heart failure and cardiorenal crosstalk

The renin-angiotensin-aldosterone-system (RAAS) plays a central role in the pathophysiology of heart failure and cardiorenal interaction. Drugs interfering in the RAAS form the pillars in treatment of heart failure and cardiorenal syndrome. Although RAAS inhibitors improve prognosis, heart failure–associated morbidity and mortality remain high, especially in the presence of kidney disease. The effect of RAAS blockade may be limited due to the loss of an inhibitory feedback of angiotensin II on renin production. The subsequent increase in prorenin and renin may activate several alternative pathways. These include the recently discovered (pro-) renin receptor, angiotensin II escape via chymase and cathepsin, and the formation of various angiotensin subforms upstream from the blockade, including angiotensin 1–7, angiotensin III, and angiotensin IV. Recently, the direct renin inhibitor aliskiren has been proven effective in reducing plasma renin activity (PRA) and appears to provide additional (tissue) RAAS blockade on top of angiotensin-converting enzyme and angiotensin receptor blockers, underscoring the important role of renin, even (or more so) under adequate RAAS blockade. Reducing PRA however occurs at the expense of an increase plasma renin concentration (PRC). PRC may exert direct effects independent of PRA through the recently discovered (pro-) renin receptor. Additional novel possibilities to interfere in the RAAS, for instance using vitamin D receptor activation, as well as the increased knowledge on alternative pathways, have revived the question on how ideal RAAS-guided therapy should be implemented. Renin and prorenin are pivotal since these are at the base of all of these pathways.

• Publication year

  2011

• Venue

  Heart Failure Reviews

• Publication date

  2011-06-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10741-011-9262-2PMID 21695549PMCID 3310995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rationale and design of the multicentre, randomized, double‐blind, placebo‐controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)

  2011cited by this paper
• Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.

  2011cited by this paper
• Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study

  2011cited by this paper
• Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction.

  2011influential reference
• The Cardiorenal Syndrome

  2011cited by this paper
• The increase in renin during renin inhibition: does it result in harmful effects by the (pro)renin receptor?

  2010cited by this paper
• Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats

  2010cited by this paper
• Activation of liver X receptor-α reduces activation of the renal and cardiac renin–angiotensin–aldosterone system

  2010cited by this paper
• A redox switch in angiotensinogen modulates angiotensin release

  2010cited by this paper
• Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

  2010cited by this paper
• Requirement of Prorenin Receptor and Vacuolar H+-ATPase–Mediated Acidification for Wnt Signaling

  2010cited by this paper
• The (Pro)renin Receptor/ATP6AP2 is Essential for Vacuolar H+-ATPase Assembly in Murine Cardiomyocytes

  2010cited by this paper
• Physiology of kidney renin.

  2010cited by this paper
• Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.

  2010cited by this paper
• Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease.

  2010cited by this paper
• Effect of Direct Renin Inhibition on Renal Hemodynamic Function, Arterial Stiffness, and Endothelial Function in Humans With Uncomplicated Type 1 Diabetes

  2009cited by this paper
• The renal renin-angiotensin system.

  2009cited by this paper
• Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy

  2009cited by this paper
• Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.

  2009cited by this paper
• Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats

  2008cited by this paper
• Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans

  2008cited by this paper
• Irbesartan in patients with heart failure and preserved ejection fraction.

  2008cited by this paper
• Suppression of renin-angiotensin gene expression in the kidney by paricalcitol.

  2008cited by this paper
• Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension1

  2008cited by this paper
• (Pro)Renin Receptor Peptide Inhibitor “Handle-Region” Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats

  2008cited by this paper
• Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure

  2008cited by this paper
• Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents

  2008cited by this paper
• Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system.

  2008cited by this paper
• Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

  2008cited by this paper
• Prorenin and Renin-Induced Extracellular Signal–Regulated Kinase 1/2 Activation in Monocytes Is Not Blocked by Aliskiren or the Handle-Region Peptide

  2008cited by this paper
• Cardiorenal syndrome.

  2008cited by this paper
• Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors

  2008cited by this paper
• Effects of human prorenin in rats transgenic for human angiotensinogen revisited

  2008cited by this paper
• Aliskiren Reduces Blood Pressure and Suppresses Plasma Renin Activity in Combination With a Thiazide Diuretic, an Angiotensin-Converting Enzyme Inhibitor, or an Angiotensin Receptor Blocker

  2007cited by this paper
• Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction

  2007influential reference
• Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors.

  2007cited by this paper
• Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure.

  2007cited by this paper
• Clinical and Genetic Correlates of Aldosterone-to-Renin Ratio and Relations to Blood Pressure in a Community Sample

  2007cited by this paper
• Decreased Intracellular Calcium Stimulates Renin Release via Calcium-Inhibitable Adenylyl Cyclase

  2007cited by this paper
• Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.

  2007cited by this paper
• Regulation of renin in mice with Cre recombinase-mediated deletion of G protein Gsalpha in juxtaglomerular cells.

  2007cited by this paper
• Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade.

  2007cited by this paper
• Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study.

  2007cited by this paper
• Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.

  2007cited by this paper
• Renin release.

  2007cited by this paper
• Functional renin receptors in renal mesangial cells

  2007cited by this paper
• Differential Inhibition of Renin mRNA Expression by Paricalcitol and Calcitriol in C57/BL6 Mice

  2007cited by this paper
• Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure

  2007cited by this paper
• Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals

  2007cited by this paper
• Novel therapies blocking the renin–angiotensin–aldosterone system in the management of hypertension and related disorders

  2007cited by this paper
• Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.

  2006cited by this paper
• Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.

  2006cited by this paper
• Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic Hypertension

  2006cited by this paper
• The Calcium Paradoxon of Renin Release: Calcium Suppresses Renin Exocytosis by Inhibition of Calcium-Dependent Adenylate Cyclases AC5 and AC6

  2006cited by this paper
• Elevated Blood Pressure and Heart Rate in Human Renin Receptor Transgenic Rats

  2006cited by this paper
• Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells.

  2005cited by this paper
• Neurohumoral pathways in heart failure with preserved systolic function.

  2005cited by this paper
• Renin, prorenin and the putative (pro)renin receptor.

  2005cited by this paper
• Transcriptional regulation of renin: an update.

  2005cited by this paper
• Contribution of the basolateral isoform of the Na-K-2Cl- cotransporter (NKCC1/BSC2) to renin secretion.

  2005cited by this paper
• Renin, prorenin and the putative (pro)renin receptor.

  2005cited by this paper
• Renal function;

  2004cited by this paper
• Direct renin assay and plasma renin activity assay compared.

  2004cited by this paper
• The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

  2004cited by this paper
• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

  2003cited by this paper
• Human Prorenin Has “Gate and Handle” Regions for Its Non-proteolytic Activation*

  2003cited by this paper
• Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

  2003cited by this paper
• 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

  2002cited by this paper
• Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.

  2002cited by this paper
• Regulation of renin expression and blood pressure by vitamin D(3).

  2002cited by this paper
• 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system

  2002cited by this paper
• A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

  2001cited by this paper
• Is there a future for renin inhibitors?

  2001cited by this paper
• 1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line

  2001cited by this paper
• Marked suppression of renin levels by β‐receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from β‐blockade

  2001cited by this paper
• Chronic beta-blocker treatment in patients with advanced heart failure. Effects on neurohormones.

  2000cited by this paper
• Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

  2000influential reference
• Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.

  2000cited by this paper
• Regulation of renin: new evidence from cultured cells and genetically modified mice

  2000cited by this paper
• Angiotensin II Formation in Human Vasculature after Chronic ACE Inhibition: A Prospective, Randomized, Placebo-Controlled Study

  2000cited by this paper
• Perindopril for elderly people with chronic heart failure: the PEP‐CHF study

  1999cited by this paper
• Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism.

  1999cited by this paper
• Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity.

  1999cited by this paper
• Dual pathway for angiotensin II formation in human internal mammary arteries

  1998cited by this paper
• Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells.

  1997cited by this paper
• Endothelins inhibit cyclic-AMP induced renin gene expression in cultured mouse juxtaglomerular cells.

  1996cited by this paper
• Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells.

  1996cited by this paper
• Aspartic proteinases: The structures and functions of a versatile superfamily of enzymes

  1995cited by this paper
• Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.

  1994cited by this paper
• Plasma renin activity and ischemic heart disease.

  1993cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality

  1991cited by this paper
• Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

  1990cited by this paper
• Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension.

  1990cited by this paper
• High plasma prorenin in diabetes mellitus and its correlation with some complications.

  1990cited by this paper
• Morphology, physiology, and molecular biology of renin secretion.

  1990cited by this paper
• Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay.

  1989cited by this paper
• Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution.

  1989cited by this paper
• Calcitonin gene-related peptide is a stimulator of renin secretion.

  1988cited by this paper
• Rat Juxtaglomerular Cells are Endowed with DA‐1 Dopamine Receptors Mediating Renin Release

  1988cited by this paper

• Effect of vitamin D on renin concentration in chronic heart failure patients: a randomized placebo-controlled trial

  2025cites this paper
• Evaluation of Large-Scale Plasma Proteomics for Prediction of Heart Failure in Individuals with A Full Range of Glucose Metabolism Profiles.

  2025cites this paper
• Renal protection in heart failure with reduced ejection fraction: not all that glitters is gold.

  2025cites this paper
• The potential therapeutic role of Lisinopril in augmenting the striatal neuroplasticity via the striatal ACE2/Ang1-7/MAS receptor axis in 3-nitropropionic acid-induced Huntington’s disease in rats: shifting paradigms in Huntington’s disease treatment

  2024cites this paper
• Efficacy and safety analysis of angiotensin receptor neprilysin inhibition(ARNI)in patients with heart failure: a real-world retrospective study

  2023cites this paper
• Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure

  2023cites this paper
• Serum renin and prorenin concentrations predict severe persistent acute kidney injury and mortality in pediatric septic shock

  2023cites this paper
• Predictive Value of Urinary Aquaporin 2 for Acute Kidney Injury in Patients with Acute Decompensated Heart Failure

  2022cites this paper
• Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options

  2022cites this paper
• Renin–angiotensin system: Basic and clinical aspects—A general perspective

  2022cites this paper
• Deciphering key genes in cardio-renal syndrome using network analysis

  2021cites this paper
• Renin–angiotensin system: Basic and clinical aspects—A general perspective

  2021cites this paper
• Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID‐19 disease

  2021cites this paper
• Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure

  2021cites this paper
• Mildly Increased Renin Expression in the Absence of Kidney Injury in the Murine Transverse Aortic Constriction Model

  2021cites this paper
• Renin-Angiotensin Aldosteron System Genes Polymorphisms and Acute Heart Failure

  2021cites this paper
• The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers

  2020cites this paper
• A continued method performance monitoring approach for the determination of pediatric renin samples – application within a European clinical trial

  2020cites this paper
• OX-HDL: A Starring Role in Cardiorenal Syndrome and the Effects of Heme Oxygenase-1 Intervention

  2020cites this paper
• Prorenin and active renin levels in paediatrics: a bioanalytical review

  2020cites this paper
• (Pro)renin Receptor Blockade Ameliorates Heart Failure Caused by Chronic Kidney Disease.

  2019cites this paper
• Renin Activity in Heart Failure with Reduced Systolic Function—New Insights

  2019influential citation
• Plasma Renin Activity Is an Independent Prognosticator in Patients With Myocardial Infarction.

  2019cites this paper
• Evaluation of Drug-Related Receptors in Children With Dilated Cardiomyopathy

  2019cites this paper
• Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study

  2018cites this paper
• OBSOLETE: Neurohormonal Blockade

  2018cites this paper
• The relationship between plasma renin activity and serum lipid profiles in patients with primary arterial hypertension

  2018cites this paper
• Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial

  2018influential citation
• Azilsartan attenuates cardiac damage caused by high salt intake through the downregulation of the cardiac (pro)renin receptor and its downstream signals in spontaneously hypertensive rats

  2018cites this paper
• (Pro)renin receptor expression in myocardial infarction in transgenic mice expressing rat tonin.

  2017cites this paper
• Deletion of protein kinase B2 preserves cardiac function by blocking interleukin-6-mediated injury and restores blood pressure during angiotensin II/high-salt-diet-induced hypertension

  2017cites this paper
• Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy

  2017cites this paper
• Excessively low salt diet damages the heart through activation of cardiac (pro) renin receptor, renin-angiotensin-aldosterone, and sympatho-adrenal systems in spontaneously hypertensive rats

  2017cites this paper
• Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension

  2017cites this paper
• Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study.

  2016cites this paper
• Sex‐linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5/6 nephrectomized Ren‐2 transgenic hypertensive rats with volume overload induced using aorto‐caval fistula

  2016cites this paper
• The predictability of renin–angiotensin–aldosterone system factors for clinical outcome in patients with acute decompensated heart failure

  2016cites this paper
• Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain.

  2016cites this paper
• Type 4 cardiorenal syndrome.

  2016cites this paper
• Natriuretic peptides and their therapeutic potential in heart failure treatment: An updated review.

  2016cites this paper
• Inhibition of Angiotensin-II Production Increases Susceptibility to Acute Ischemia/Reperfusion Arrhythmia

  2016cites this paper
• Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin–Angiotensin System

  2016cites this paper
• Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy

  2015cites this paper
• High Salt Intake Damages the Heart through Activation of Cardiac (Pro) Renin Receptors Even at an Early Stage of Hypertension

  2015cites this paper
• Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction

  2015cites this paper
• Plasma renin activity is a strong and independent prognostic indicator in patients with acute decompensated heart failure treated with renin-angiotensin system inhibitors.

  2015cites this paper
• Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.

  2015cites this paper
• New roles for renin in heart failure and cardio-renal interaction

  2015cites this paper
• Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren‐2 transgenic hypertensive rats with aorto‐caval fistula

  2015cites this paper
• Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure.

  2014cites this paper
• Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke.

  2014cites this paper
• Can renin inhibition by Aliskiren prove itself in atherosclerosis prevention?

  2014influential citation
• The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure

  2014cites this paper
• The Angiotensin-Receptor Neprilysin Inhibitor LCZ 696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy

  2014cites this paper
• Cardiac Function and Architecture Are Maintained in a Model of Cardiorestricted Overexpression of the Prorenin-Renin Receptor

  2014cites this paper
• Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.

  2013cites this paper
• Renin–Angiotensin–Aldosterone System Inhibitors in Heart Failure

  2013cites this paper
• Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).

  2013cites this paper
• Targeting the renin–angiotensin–aldosterone system in heart failure

  2013cites this paper
• RENIN ANGIOTENSIN SYSTEM AND ITS THERAPEUTIC APPROACHES

  2013influential citation
• Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease

  2012cites this paper
• The puzzle of kidney dysfunction in heart failure: an introduction

  2012cites this paper
• Cardiorenal interaction : experimental and clinical studies

  2012cites this paper
• The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?

  2012cites this paper
• Plasma renin and outcome in the community: data from PREVEND.

  2012cites this paper
• Renal and systemic angiotensinogen in Heart Failure patients

  2012cites this paper
• Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study

  2012cites this paper
• Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.

  2011cites this paper
• Regulation of the (pro)renin–renin receptor in cardiac remodelling

  2011cites this paper
• Clinical Applications of Renin-Angiotensin System Inhibitors

  2011cites this paper
• Angiotensin Receptor Neprilysin Inhibitor LCZ 696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy

  year unknowncites this paper
• Angiotensin Receptor Neprilysin Inhibitor LCZ 696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy

  year unknowncites this paper
• Endocrinología, Diabetes y Nutrición

  year unknowncites this paper
• Angiotensin Receptor Neprilysin Inhibitor LCZ 696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy

  year unknowncites this paper